1 Vernon G,
Baranova A,
Younossi ZM.
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
Aliment Pharmacol Ther 2011;34:274–85.
doi:10.1111/j.1365-2036.2011.04724.x
2 Hamer OW,
Aguirre DA,
Casola G,
et al. Fatty liver: imaging patterns and pitfalls.
Radiogr Rev Publ Radiol Soc N Am Inc 2006;26:1637–53.
doi:10.1148/rg.266065004
3 Bartolotta TV,
Taibbi A,
Picone D,
et al. Detection of liver metastases in cancer patients with geographic fatty infiltration of the liver: the added value of contrast-enhanced sonography.
Ultrasonography 2017;36:160–9.
doi:10.14366/usg.16041
4 Yalamanchi V,
Wang W,
Bunim A.
Education and Imaging.
Hepatobiliary and Pancreatic: Focal fatty infiltration of the liver mimicking malignancy in high-risk patients.
J Gastroenterol Hepatol 2015;30:1228.
doi:10.1111/jgh.12960
5 Tebala GD,
Jwad A,
Khan AQ,
et al. Multifocal Nodular Fatty Infiltration of the Liver: A Case Report of a Challenging Diagnostic Problem.
Am J Case Rep 2016;17:196–202.
6 Pais TP,
Fernandes S,
Fraga J.
Multiple liver lesions of unusual benign etiology mimicking metastatic disease.
Gastroenterology 2014;147:e10–11.
doi:10.1053/j.gastro.2014.03.039
7 Tapper EB,
Lok AS-F.
Use of Liver Imaging and Biopsy in Clinical Practice.
N Engl J Med 2017;377:756–68.
doi:10.1056/NEJMra1610570
8 Lee SS,
Park SH,
Kim HJ,
KIM SY,
Kim My,
Kim DY, Suh DJ,
Kim KM,
Bae MH,
Lee JY,
et al.
Non-invasive assessment of hepatic steatosis: prospective comparison of accuracy of imaging examinations.
J Hepatol.
2010;52:579-585.
9 Amacher DE,
Chalasani N.
Drug-induced hepatic steatosis.
Semin Liver Dis 2014;34:205–14.
doi:10.1055/s-0034-1375960
10 TangY,
Tamashita Y,
Ogata l,
et al.
Metastatic liver tumor from cystic ovarian carcinomas: Ct and MRI appearance.
Radiat Med 1999; 17: 265-270.
11 HalvorsenRA,
Korobkin M,
Foster WL,
Silverman Pm,
Thompson WM.
The variable CT appearance of hepatic abscesses.
AJR Am J Roentgenol 1984; 142: 941 - 946.